Drug therapy for childhood epilepsy.

[1]  S. Livingston,et al.  Celontin (PM-396) in the treatment of epilepsy. , 1957, Pediatrics.

[2]  G. Tait.  Fatal agranulocytosis during carbimazole therapy. , 1957, Lancet.

[3]  M. G. Peterman.  The present status of idiopathic epilepsy. , 1954, Wisconsin medical journal.

[4]  S. Livingston.  The use of peganone (AC 695) in the treatment of epilepsy. , 1956, The Journal of pediatrics.

[5]  M. Perlstein.  Use of meprobamate (Miltown) in convulsive and related disorders. , 1956, Journal of the American Medical Association.

[6]  S. Isaacson,et al.  Fatal aplastic anemia after therapy with nuvarone (3-methyl-5-phenylhydantoin). , 1956, Journal of the American Medical Association.

[7]  S. Livingston,et al.  Ineffectiveness of diamox in the treatment of childhood epilepsy. , 1956, Pediatrics.

[8]  A. Gropper.  Diphenylhydantoin sensitivity; report of fatal case with hepatitis and exfoliative dermatitis. , 1956, The New England journal of medicine.

[9]  S. Livingston,et al.  Primidone (mysoline) in the treatment of epilepsy; results of treatment of 486 patients and review of the literature. , 1956, The New England journal of medicine.

[10]  R. Schwab,et al.  Diphenylhydantoin (dilantin) sodium used parenterally in control of convulsions; a five-year report. , 1956, Journal of the American Medical Association.

[11]  C. Lombroso,et al.  Further evaluation of acetazolamide (diamox) in treatment of epilepsy. , 1956, Journal of the American Medical Association.

[12]  M. Morgan,et al.  Thrombocytopenia following acetazolamide (diamox) therapy. , 1956, Journal of the American Medical Association.

[13]  E. Fisher,et al.  Renal lesions of sulfonamide type after treatment with acetazolamide (diamox). , 1956, Journal of the American Medical Association.

[14]  J. Lenman,et al.  Megaloblastic Anaemia Occurring During Primidone Therapy , 1956, British medical journal.

[15]  W. Craddock.  Use of phenacemide in epilepsy, with analysis of fatal reactions and case report. , 1955, Journal of the American Medical Association.

[16]  Zimmerman Ft.  Milontin in the treatment of epilepsy. , 1955 .

[17]  C. Ounsted.  The hyperkinetic syndrome in epileptic children. , 1955, Lancet.

[18]  C. Markham,et al.  Methylphenylsuccinimide (milontin) in epilepsy. , 1955, The New England journal of medicine.

[19]  S. Livingston,et al.  Ineffectiveness of pyridoxine (vitamin B6) in the treatment of epilepsy. , 1955, Pediatrics.

[20]  S. Livingston,et al.  Use of the dione drugs (propazone, tridione, paradione, dimedione and malidone) in the treatment of epilepsy of children. , 1955, The New England journal of medicine.

[21]  G. M. Ryan,et al.  Megaloblastic Anaemia Due to Phenytoin Sodium , 1955, British medical journal.

[22]  N. Berlyne,et al.  Megaloblastic Anaemia Following Anticonvulsants , 1955, British medical journal.

[23]  Burrell Zl.  Fatal pancytopenia as a result of improperly supervised mesantoin therapy. , 1955 .

[24]  F. T. Zimmerman,et al.  Drugs used in treatment of patients with petit mal epilepsy; a serial evaluation of new and standard drugs with alternate placebo baselines in identical cases. , 1955, Journal of the American Medical Association.

[25]  R. Schwab,et al.  Mysoline; an effective anticonvulsant with initial problems of adjustment. , 1955, The New England journal of medicine.

[26]  D. B. Tower.  Nature and Extent of the Biochemical Lesion in Human Epileptogenic Cerebral Cortex , 1955, Neurology.

[27]  C. Binder,et al.  Agranulocytosis following diamox therapy. , 1955, Journal of the American Medical Association.

[28]  F. T. Zimmerman,et al.  USE OF N-METHYL-a,a-METHYLPHENYLSUCCINIMIDE IN TREATMENT OF PETIT MAL EPILEPSY , 1954 .

[29]  Carter Ch.  Use of Milontin in the Control of Petit Ma1 Epilepsy , 1954 .

[30]  J. Webster.  MEGALOBLASTIC ANÆMIA DUE TO PHENYTOIN SODIUM , 1954 .

[31]  Moore Mt.  The treatment of the epileptic individual. , 1954 .

[32]  S. Merlis.  Diamox: A Carbonic Anhydrase Inhibitor Its Use in Epilepsy , 1954, Neurology.

[33]  S. Váradi,et al.  Megaloblastic anaemia due to phenytoin sodium. , 1954, Lancet.

[34]  J. Chalmers,et al.  Megaloblastic anaemia and anticonvulsant therapy. , 1954, Lancet.

[35]  C. Millman,et al.  Primidone in Treatment of Epilepsy , 1954 .

[36]  M. Meynell,et al.  Megaloblastic anaemia due to phenytoin sodium. , 1954, Lancet.

[37]  Zimmerman Ft.  Milontin and other new drugs in the treatment of petit mal epilepsy. , 1954 .

[38]  D. Sharpe.  Primidone in Mental Deficiency Practice , 1954, British medical journal.

[39]  L. Liversedge,et al.  Primidone in the Treatment of Epilepsy , 1954, British medical journal.

[40]  W. S. Fields,et al.  Combined drug therapy in petit mal epilepsy. , 1954, The Journal of pediatrics.

[41]  R. Dreyer.  [Experiences with mesantoin]. , 1954, Deutsche medizinische Wochenschrift.

[42]  R. Justi,et al.  Fatal hepatitis after phenurone therapy for epilepsy. , 1954, The New England journal of medicine.

[43]  M. L. Blumberg.  Abdominal epilepsy; report of a case controlled with tridione. , 1954, The Journal of pediatrics.

[44]  Pence Lm.  Mysoline in epilepsy. , 1954 .

[45]  F. Lemere.  Milontin in treatment of petit mal epilepsy. , 1954, Northwest medicine.

[46]  H. Merritt,et al.  Clinical evaluation of primidone (Mysoline), new anticonvulsant drug. , 1954, Journal of the American Medical Association.

[47]  F. M. Forster,et al.  Mysoline and Milontin , 1954, Neurology.

[48]  J. Stokes,et al.  Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. , 1954, Pediatrics.

[49]  L. Goodman,et al.  Effects of liver damage and nephrectomy on anticonvulsant activity of mysoline and phenobarbital. , 1954, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[50]  A. H. Parmelee,et al.  Convulsions in young infants as a result of pyridoxine (vitamin B6) deficiency. , 1954, Journal of the American Medical Association.

[51]  D. Coursin.  Convulsive seizures in infants with pyridoxine-deficient diet. , 1954, Journal of the American Medical Association.

[52]  S. Goldin.  Toxic effects of primidone. , 1954, Lancet.

[53]  J. Briggs,et al.  Primidone (mysoline) in the treatment of clinical petit mal in children. , 1954, Lancet.

[54]  P. Nathan.  Primidone in the treatment of non-idiopathic epilepsy. , 1954, Lancet.

[55]  F. Gibbs,et al.  Diagnosis and prognosis of hypsarhythmia and infantile spasms. , 1954, Pediatrics.

[56]  S. Livingston.  The use of hibicon in the treatment of epilepsy. , 1953, The Journal of pediatrics.

[57]  R. Nutt,et al.  Nephrotic syndrome occurring during paramethadione therapy; report of a case with clinical remission. , 1953, Journal of the American Medical Association.

[58]  J. Game.  “MYSOLINE”—ITS USE IN EPILEPSY , 1953, The Medical journal of Australia.

[59]  G. Jørgensen.  MYSOLINE IN THE TREATMENT OF EPILEPSY , 1953 .

[60]  S. Livingston,et al.  The use of mysoline in the treatment of epilepsy. , 1953, The Journal of pediatrics.

[61]  M. Perlstein.  Prenderol: A New Drug Used With Retarders in Petit Mal Epilepsy , 1953, Neurology.

[62]  M. Sapirstein,et al.  Treatment of epilepsy with mysoline. , 1953, A.M.A. archives of neurology and psychiatry.

[63]  C. Whitty.  Value of Primidone in Epilepsy , 1953, British medical journal.

[64]  G. Gammon,et al.  A CLINICAL EVALUATION OF MESANTOIN IN EPILEPSY , 1953, The Journal of nervous and mental disease.

[65]  T. J. Putnam,et al.  Results of intensive (narcosis) and standard medical treatment of epilepsy. , 1953, Journal of the American Medical Association.

[66]  P. Pearson,et al.  Use of milontin in the treatment of petit mal epilepsy (three per second spike and wave dysrhythmia). , 1953, The Journal of pediatrics.

[67]  W. H. Marshall,et al.  Convulsant effects of isoniazid. , 1953, Journal of the American Medical Association.

[68]  L. Goodman,et al.  Anticonvulsant properties of 5-phenyl-5-ethyl-hexahydropyrimidine-4,6-dione (mysoline), a new antiepileptic. , 1953, The Journal of pharmacology and experimental therapeutics.

[69]  P. Pearson,et al.  Thrombocytopenic purpura occurring in association with paradione (paramethadione) and dilantin sodium (phenytoin sodium) therapy. , 1953, Jornal de Pediatria.

[70]  A. Bonkalo,et al.  Mysoline in treatment of epileptic and non-epileptic psychiatric patients. , 1953, Canadian Medical Association journal.

[71]  J. Millichap,et al.  Nephrotoxic effects of drugs used in treatment of petit mal. , 1953, Lancet.

[72]  A. Butter.  Mysoline in the treatment of epilepsy. , 1953, Lancet.

[73]  W. Gilson,et al.  Ammonium Chloride as an Adjuvant to Anticonvulsant Medication in Epilepsy , 1953, Neurology.

[74]  F. Mcnaughton,et al.  Mysoline, a new anticonvulsant drug; its value in refractory cases of epilepsy. , 1953, Canadian Medical Association journal.

[75]  R. Swartout.  Two cases of fatal pancytopenia following mesantoin therapy. , 1953, California medicine.

[76]  G. Chen,et al.  The combined anticonvulsant activity and toxicity of dilantin and N-methyl-5-phenylsuccinimide. , 1953, The Journal of laboratory and clinical medicine.

[77]  W. M. Wallace,et al.  Observations on the metabolic and clinical effects of carbonic-anhydrase inhibitors in epileptics. , 1952, A.M.A. American journal of diseases of children.

[78]  J. Millichap.  Milontin: a new drug in the treatment of petit mal. , 1952, Lancet.

[79]  P. Pearson,et al.  Fatal pancytopenia following therapy with nuvarone (3-methyl, 5-phenylhydantoin); a case report. , 1952, Bulletin of the Johns Hopkins Hospital.

[80]  M. G. Peterman.  Treatment of convulsions in childhood. , 1952, A.M.A. American journal of diseases of children.

[81]  L. Crome.  The Histological Changes in Hydantoinate Gingivitis , 1952, Journal of clinical pathology.

[82]  I. Sneddon,et al.  Severe and Fatal Phenobarbitone Eruptions , 1952, British medical journal.

[83]  C. D. Hawkes.  N-BENZYL-β-CHLOROPROPIONAMIDE (HIBICON®): A New Approach to Anticonvulsant Therapy , 1952 .

[84]  J. Nabarro,et al.  Nephrotic syndrome complicating tridione (troxidone) therapy. , 1952, Lancet.

[85]  R. Handley,et al.  Mysoline; a new drug in the treatment of epilepsy. , 1952, Lancet.

[86]  J. Bastié,et al.  [Electroshock under phenacetylurea]. , 1952, La Presse medicale.

[87]  S. Maslanka,et al.  Hibicon a new anticonvulsant. , 1952, Diseases of the nervous system.

[88]  C. Pryles,et al.  Acute hepatic necrosis with death occurring during phethenylate sodium therapy; report of two cases. , 1952, Journal of the American Medical Association.

[89]  H. Gallager,et al.  Fatal hepatic necrosis occurring during therapy with phethenylate sodium. , 1952, Journal of the American Medical Association.

[90]  S. Brandt.  [Phenacetylurea as an antiepileptic agent]. , 1952, Ugeskrift for laeger.

[91]  P. Yates,et al.  Acute yellow atrophy of the liver following treatment with phenylacetyl-urea. , 1952, Lancet.

[92]  M. Waid,et al.  Aplasia of the bone marrow during mesantoin therapy; report of a fatal case. , 1951, Journal of the American Medical Association.

[93]  D. Jenkins,et al.  Occurrence of skin pigmentation during mesantoin therapy. , 1951, Journal of the American Medical Association.

[94]  M. Tyler,et al.  Phenacemide in treatment of epilepsy. , 1951, Journal of the American Medical Association.

[95]  F. T. Zimmerman.  Use of methylphenyl-succinimide in treatment of petit mal epilepsy. , 1951, A.M.A. archives of neurology and psychiatry.

[96]  G. F. Perry,et al.  Phenacetylurea in convulsive disorders. , 1951, Diseases of the nervous system.

[97]  C. Bradley.  Behavior disturbances in epileptic children. , 1951, Journal of the American Medical Association.

[98]  B. Pasamanick.  Anticonvulsant drug therapy of behavior problem children with abnormal electroencephalograms. , 1951, A.M.A. archives of neurology and psychiatry.

[99]  J. K. Merlis.  Medical Treatment of Psychomotor Epilepsy , 1951, Neurology.

[100]  R. Dejong.  Phenurone in the treatment of psychomotor attacks. , 1951, The American journal of psychiatry.

[101]  Gordan Gs,et al.  Sublingual desoxycorticosterone for the control of convulsive seizures. , 1951 .

[102]  F. Gibbs,et al.  The surgical treatment of psychomotor epilepsy. , 1951, Journal of the American Medical Association.

[103]  R. Forsey,et al.  Tridione and paradione sensitivity. , 1951, Canadian Medical Association journal.

[104]  F. M. Forster.  Therapy in psychomotor epilepsy. , 1951, Journal of the American Medical Association.

[105]  H. M. Keith.  Use of phenurone in convulsive disorders in children. , 1950, A.M.A. American journal of diseases of children.

[106]  S. Livingston,et al.  The effect of adrenocorticotropic hormone in epilepsy. , 1950, The Journal of pediatrics.

[107]  R. Schwab,et al.  The serious side effects of the newer antiepileptic drugs: their control and prevention. , 1950, The New England journal of medicine.

[108]  S. Aronson,et al.  Fatal hepatorenal syndrome associated with phenurone therapy. , 1950, The New England journal of medicine.

[109]  J. Segal,et al.  Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. , 1950, The New England journal of medicine.

[110]  Davidson Dt,et al.  Phenacetylurea-(phenurone)-in epilepsy. , 1950 .

[111]  E. B. Wilson,et al.  Fatal aplastic anemia occurring during anticonvulsant therapy: probable idiosyncrasy to phenurone. , 1950, Annals of internal medicine.

[112]  D. G. Welton.  Exfoliative dermatitis and hepatitis due to phenobarbital. , 1950, Journal of the American Medical Association.

[113]  Lloyd-Smith Dl.  Phenurone and hepatitis. , 1950 .

[114]  G. Heller,et al.  Erythema bullosum malignans following dilantin therapy. , 1950, Pediatrics.

[115]  H. Merritt,et al.  Phenylacetylurea in the treatment of convulsive seizures. , 1950, Diseases of the nervous system.

[116]  S. Little,et al.  THE USE OF PHENYLACETYLUREA (PHENURONE) IN CONVULSIVE DISORDERS , 1950, The American journal of the medical sciences.

[117]  M. Perlstein.  GEMONAL® (5,5-DIETHYL 1-METHYL BARBITURIC ACID) , 1950, Pediatrics.

[118]  H. L. Kozol.  MESANTOIN® IN TREATMENT OF EPILEPSY: A Report on Two Hundred Patients Under Treatment for Periods Ranging from Two Months to Four Years , 1950 .

[119]  S. Livingston,et al.  The use of phenurone in the treatment of epilepsy. , 1950, The Journal of pediatrics.

[120]  W. Best,et al.  Severe hypoplastic anemia following anticonvulsant medication; review of the literature and report of a case. , 1950, The American journal of medicine.

[121]  F. M. Forster,et al.  Insensitivity to pain as a complication of phenurone therapy in epilepsy. , 1950, Diseases of the nervous system.

[122]  Berry An.  Fatality following tridione. , 1949 .

[123]  Campbell Jd.  Bromide intoxication; report of 36 cases. , 1949 .

[124]  S. Livingston,et al.  Tridione therapy in epilepsy; a review of results in 156 patients with petit mal epilepsy with special reference to side reactions. , 1949, The Journal of pediatrics.

[125]  S. Kaplan,et al.  Fatal aplastic anemia following tridione administration. , 1949, Diseases of the nervous system.

[126]  N. J. Weiser,et al.  FATAL AGRANULOCYTOSIS DUE TO TRIMETHADIONE (TRIDIONE , 1949 .

[127]  F. C. Haward.  “Tridione” in Petit Mal , 1949 .

[128]  C. Whitty.  “Tridione” in Treatment of Epilepsy* , 1949, British medical journal.

[129]  M. Zeifert.  Phenurone in epilepsy. , 1949, Diseases of the nervous system.

[130]  R. Weller,et al.  Fatal pancytopenia following the use of mesantoin; report of a case. , 1949, The New England journal of medicine.

[131]  I. Kaufman,et al.  Hepatitis, exfoliative dermatitis and abnormal bone marrow occurring during tridione therapy; report of a case with recovery. , 1949, The New England journal of medicine.

[132]  J. Spillane,et al.  Tridione therapy in minor epilepsy. , 1949, Brain : a journal of neurology.

[133]  V. Davenport,et al.  Brain and plasma cations and experimental seizures in normal and desoxycorticosterone-treated rats. , 1949, The American journal of physiology.

[134]  J. W. Watson,et al.  Agranulocytosis and thrombocytopenia following the use of tridione. , 1949, Lancet.

[135]  W. Lennox,et al.  A comparison of paradione and tridione in the treatment of epilepsy , 1949 .

[136]  V. Davenport.  Relation between brain and plasma electrolytes and electroshock seizure thresholds in adrenalectomized rats. , 1949, The American journal of physiology.

[137]  J. White.  Nephrosis occurring during trimethadione therapy; report of a case. , 1949, Journal of the American Medical Association.

[138]  D. Mceachern,et al.  Acute aplastic anaemia during mesantoin therapy. , 1949, Canadian Medical Association journal.

[139]  R. K. Richards,et al.  Phenurone in epilepsy. , 1949, Diseases of the nervous system.

[140]  J. Emery,et al.  Toxic effects of tridione. , 1949, Lancet.

[141]  M. G. Peterman.  Epilepsy in childhood; newer methods of diagnosis and treatment. , 1948, Journal of the American Medical Association.

[142]  Lennox Ma.  Drug treatment of epilepsy. , 1948 .

[143]  David Na,et al.  Methyl hydantoin in the treatment of epilepsy. , 1948 .

[144]  D. Ruskin.  Fulminating dermatitis bullosa medicamentosa due to mesantoin. , 1948, Journal of the American Medical Association.

[145]  Rickles Nk.  Mesantoin in treatment of epilepsy. , 1948 .

[146]  P. Morris,et al.  Severe erythema multiforme of the pluriorificial type, Stevens-Johnson syndrome, resulting in blindness in a patient treated with trimethadione. , 1948, Pediatrics.

[147]  R. Wells,et al.  Nephrotic syndrome occurring during tridione therapy. , 1948, The American journal of medicine.

[148]  J. V. Van Wyk,et al.  Periarteritis nodosa; a case of fatal exfoliative dermatitis resulting from dilantin sodium sensitization. , 1948, Archives of internal medicine.

[149]  C. Tedeschi,et al.  Fatal acute pancytopenia following tridione treatment. , 1948, The New England journal of medicine.

[150]  R. Aird.  THE TREATMENT OF EPILEPSY WITH METHYLPHENYLETHYL HYDANTOIN (MESANTOIN). , 1948, California medicine.

[151]  J. Kerrin.  FATALITIES FROM TRIDIONE , 1948 .

[152]  A. Butter.  “Tridione” in the Treatment of Petit Mal , 1948, British medical journal.

[153]  R. Braithwaite.  Fatal Case of Agranulocytosis Associated with “Tridione” Therapy , 1948, British medical journal.

[154]  Schoemperlen Cb.  Agranulocytosis due to dilantin sodium. , 1947 .

[155]  W. Lennox.  Tridione in the treatment of epilepsy. , 1947, Journal of the American Medical Association.

[156]  Merritt Hh.  Recent advances in treatment of epilepsy, with particular emphasis on use of tridione. , 1947 .

[157]  C. F. Walker,et al.  Dilantin treatment for behavior problem children with abnormal electroencephalograms. , 1947, The American journal of psychiatry.

[158]  R. P. Mackay,et al.  APLASTIC ANEMIA AND AGRANULOCYTOSIS FOLLOWING TRIDIONE: A Fatal Case , 1946 .

[159]  J. T. Fox,et al.  Pyridoxine (vitamin B6) in epilepsy; a clinical trial. , 1946, Lancet.

[160]  F. F. Harrison,et al.  Fatal aplastic anemia following use of tridione and a hydantoin. , 1946, Journal of the American Medical Association.

[161]  R. Dejong.  FURTHER OBSERVATIONS ON THE USE OF TRIDIONE IN THE CONTROL OF PSYCHOMOTOR ATTACKS , 1946 .

[162]  H. L. Kozol.  Epilepsy; treatment with new drug; 3-methyl 5,5-phenyl-ethyl-hydantoin (phenantoin). , 1946, The American journal of psychiatry.

[163]  M. Perlstein,et al.  Tridione; its use in convulsive and related disorders. , 1946, The Journal of pediatrics.

[164]  R. Dejong.  Effect of tridione in the control of psychomotor attacks. , 1946, Journal of the American Medical Association.

[165]  W. Lennox.  The petit mal epilepsies; their treatment with tridione. , 1945, Journal of the American Medical Association.

[166]  F. C. Thorne.  The anticonvulsant action of tridione , 1945, The Psychiatric quarterly.

[167]  A. E. Loscalzo.  TREATMENT OF EPILEPTIC PATIENTS WITH A COMBINATION OF 3‐METHYL 5,5 PHENYLETHYL‐HYDANTOIN AND PHENOBARBITAL: (PRELIMINARY REPORT) , 1945 .

[168]  P. White,et al.  Sodium Dilantin Gingival Hyperplasia , 1945 .

[169]  A. Arieff,et al.  Electrocardiographic changes resulting from dilantin medication , 1943 .

[170]  E. B. Ritchie,et al.  REACTION TO SODIUM DIPHENYL HYDANTOINATE (DILANTIN SODIUM): HEMORRHAGIC ERYTHEMA MULTIFORME TERMINATING FATALLY , 1942 .

[171]  E. Weir.  THE INFLUENCE OF THE SERUM BROMIDE CONCENTRATION UPON THE DISTRIBUTION OF BROMIDE ION BETWEEN SERUM AND SPINAL FLUID , 1942 .

[172]  I. Mcquarrie,et al.  Observations on the Antagonistic Effects of Posterior Pituitary and Cortico-Adrenal Hormones in, the Epileptic Subject1 , 1942 .

[173]  A. Arieff,et al.  UNTOWARD EFFECTS OF PHENYTOIN SODIUM IN EPILEPSY , 1942 .

[174]  W. W. Dickerson.  THE PRESENT STATUS OF DILANTIN THERAPY , 1942 .

[175]  L. Robinson.  AMPHETAMINE (BENZEDRINE) SULFATE AS A CORRECTIVE FOR THE DEPRESSION OF SEDATIVE MEDICATION IN EPILEPSY , 1941 .

[176]  H. Mandelbaum,et al.  DILANTIN SODIUM POISONING: REPORT OF A CASE WITH DERMATITIS EXFOLIATIVA, PYREXIA AND HEPATIC AND SPLENIC ENLARGEMENT , 1941 .

[177]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[178]  C. Aring,et al.  INGESTION OF LARGE DOSES OF DILANTIN SODIUM , 1941 .

[179]  B. Williamson.  Severe Toxic Effects of Sodium Diphenyl Hydantoinate in Mentally Defective Epileptics , 1940 .

[180]  A. Arieff,et al.  A NOTE ON THE USELESSNESS OF ANALEPTIC DRUGS COMBINED WITH LUMINAL IN THE TREATMENT OF EPILEPSY , 1940 .

[181]  Denis Williams.  TREATMENT OF EPILEPSY WITH SODIUM DIPHENYL HYDANTOINATE , 1939 .

[182]  O. P. Kimball.  THE TREATMENT OF EPILEPSY WITH SODIUM DIPHENYL HYDANTOINATE , 1939 .

[183]  B. Brodie,et al.  THE DISTRIBUTION OF ADMINISTERED BROMIDE IN COMPARISON WITH CHLORIDE AND ITS RELATION TO BODY FLUIDS , 1939 .

[184]  A. Myerson,et al.  THE EFFECTIVE USE OF PHENOBARBITAL AND BENZEDRINE SULFATE (AMPHETAMINE SULFATE) IN THE TREATMENT OF EPILEPSY , 1938 .

[185]  L. J. Pollock.  REMISSIONS OF ATTACKS IN EPILEPSY TREATED WITH SODIUM BROMIDE , 1938 .

[186]  H. Clarke,et al.  THE ELIMINATION OF BROMIDES FROM THE BLOOD STREAM , 1933 .

[187]  F. Talbot.  Treatment of Epilepsy , 1931 .

[188]  J. Notkin.  CHLORIDE-BROMIDE TREATMENT IN EPILEPSY , 1929 .

[189]  J. T. Fox.  LUMINAL-SODIUM IN THE TREATMENT OF EPILEPSY. , 1927 .